The Patent Finder

Marius Pharmaceuticals, Inc.

31 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
15
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 20, 2026
    The maintenance fee for Ganaxolone for Use in Treatment of Status Epilepticus (US 11,679,117) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
  • 1 fee due Jan 18, 2027
    The maintenance fee for Ganaxolone for Use in Treating Tuberous Sclerosis Complex (US 11,701,367) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
  • 1 fee due Feb 27, 2027
    The maintenance fee for Methods of Treating Certain Depressive Disorders and Delirium Tremens (US 10,391,105) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 2 fees due Sep 3, 2027
  • 2 fees due Nov 5 to 14, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,367,651Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,618,087Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,029,355Solid Ganaxolone Compositions and Methods for the Making and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,056,116Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,452,176Solid Ganaxolone Compositions and Methods for the Making and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,071,740Method of Treatment Using Nanoparticulate Ganaxolone Formulations
In force
 · Medium confidence
In forceMedium confidence
US 7,858,609Solid Ganaxolone Formulations and Methods for the Making and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,022,054Liquid Ganaxolone Formulations and Methods for the Making and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,017,728Stable Corticosteroid Nanoparticulate Formulations and Methods for the Making and Use thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,455,002Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof
In force
 · Medium confidence
In forceMedium confidence
10 of 31 patents shown.
Pro members see all 31.
Pro members: see all 31 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited